Set as preferred source
Insights from AI in Practice: Shaping the Future of Healthcare Now.
Healthcare AI is entering a quieter but more consequential phase than the first wave of experimentation suggested.
The early narrative focused on individual use cases: faster image analysis, better triage, automated clinical notes, and diagnostic support. Those applications still matter. But the larger shift is now structural. AI is beginning to change how health systems manage time, expertise, data, and trust. That makes the next phase less about adoption and more about integration.
The difference matters. Adoption asks whether clinicians and organizations use AI. Integration asks whether AI can become part of the operating model without introducing new vulnerabilities. The Philips Future Health Index 2026, based on surveys of more than 2,000 healthcare professionals and 20,000 patients across 10 countries, depicts a sector already reporting measurable gains but still constrained by fragmented infrastructure, uneven training, and governance gaps.
The strategic signal is clear: healthcare AI is beginning to demonstrate value in practice. The next challenge is building systems capable of scaling that value safely.
AI is moving from promise to operational impact
The strongest finding is not that healthcare professionals are optimistic about AI. It is that they are already reporting operational benefits.
Among surveyed clinicians, 71% report improved workflow efficiency, 67% report faster diagnostic decision-making, and 65% report greater confidence in their decisions. Half say AI has increased their capacity to see more patients. Among those clinicians, the median increase is eight additional patients per week globally.
These are not merely abstract productivity gains. They suggest a potential shift in the economics of care delivery. In systems where demand keeps rising and clinical labor remains constrained, capacity is not simply an efficiency metric. It becomes a critical measure of system resilience.
That is why AI’s value case is changing. Earlier investment decisions focused on innovation portfolios and pilot outcomes. The emerging logic is closer to infrastructure: Can AI improve throughput, protect clinical time, reduce avoidable risk, and support care delivery under workforce pressure?
China illustrates the faster-moving end of this trend. Among Chinese clinicians who report increased capacity, the median increase is 30 additional patients per week. The figure should not be treated as a universal benchmark. It may, however, indicate what is possible when AI deployment is closely aligned with capacity goals.
Saudi Arabia, China, and the US also show high levels of personal AI use when workplace tools fall short, suggesting that frontline demand is moving faster than formal institutional deployment. That gap is becoming one of the sector’s most important risks.
Shadow AI is a symptom of unmet institutional demand
Sixty-four percent of surveyed healthcare professionals use personal AI tools when workplace options do not meet their needs. That finding deserves more attention than many adoption statistics.
It shows that clinicians are not waiting for enterprise systems to become ready. They are solving immediate workflow problems with whatever tools are available. In the short term, this can improve individual productivity. Over time, however, it can create unmanaged variation in how information is processed, summarized, verified, and applied.
This is not simply a cybersecurity or compliance issue. It is an operating-model issue. When unofficial tools become part of clinical work, organizations lose visibility into the decision-support environment. They may remain accountable for outcomes while having limited control over the systems influencing those outcomes.
The more useful interpretation is that shadow AI reflects unmet demand. Clinicians use personal tools because the formal technology stack is too slow, too fragmented, or too poorly integrated into daily work. Restriction alone is not the answer. Organizations need trusted infrastructure that offers the speed and usability of informal tools while preserving clinical accountability.
The greater opportunity is a connected intelligence layer
Much of the AI conversation in healthcare still uses the language of individual tools. One tool schedules. Another transcribes. Others analyze scans or flag risks.
But the more consequential shift is the emergence of AI as an intelligence layer across fragmented systems.
Fifty-seven percent of clinicians report improved access to consolidated patient data across care teams. This matters because health systems have spent years accumulating data without making it reliably usable at the point of decision. Records sit in different systems. Imaging, notes, laboratory results, device outputs, and operational workflows often remain disconnected. Clinicians then carry the burden of synthesizing that information under time pressure.
AI broadens the role of interoperability. When combined with AI, interoperability can support a safety and decision layer that assembles relevant clinical context before a procedure, diagnosis, or intervention.
The distinction is important. A connected data system allows information to be shared. An intelligence layer can help identify what might otherwise be missed.
That is where AI begins to move from administrative support into clinical infrastructure. It can reduce search time, surface patterns, flag overlooked risks, and give care teams a more complete view of the patient journey. The value lies not in replacing clinical judgment but in improving the conditions under which it is applied.
Time savings need protection, or they disappear
AI is already giving clinicians time back. Forty-six percent of clinicians report saving at least 132 hours annually, based on a median weekly saving of three hours.
In a stretched health system, that sounds like an immediate win. But the report also shows a more uncomfortable reality: nearly one-quarter of clinicians say the time they save is quickly absorbed by other demands.
This is where many AI business cases become weaker than they appear on paper. Time saved is not the same as value captured. If AI reduces documentation time but the freed capacity is immediately consumed by additional administrative work, meetings, backlogs, or fragmented processes, the return becomes diluted.
The strategic issue is time protection. AI creates a pool of recovered capacity, but institutions determine whether that capacity leads to better patient interactions, more careful clinical review, reduced burnout, faster throughput, or simply more work.
That makes implementation design as important as the tool itself. Without a clear operating model for reinvesting saved time, the productivity gains from AI can be lost to other operational demands.
Clinical safety is becoming a significant investment signal
One of the report’s most important findings sits beyond the usual productivity narrative: 39% of clinicians say AI has helped them identify or prevent a potential medical error at least three times in the past three months.
That moves the AI value case into a different category.
Medical errors carry human and reputational costs, create liability exposure, and disrupt operations. If AI can consistently help clinicians detect unsafe drug combinations, identify deterioration, surface missing information, or review diagnoses, its financial value may extend beyond efficiency. It may become part of a broader risk-reduction strategy.
The broader financial signal is also beginning to emerge. Thirty-four percent of healthcare leaders report budget savings, while 62% say the benefits of their AI investments are meeting or exceeding costs.
This does not remove the need for oversight. In fact, it strengthens it. Safety-related AI can work at scale only if its performance is monitored, its recommendations can be challenged, and clinicians remain accountable for final decisions. But the direction is significant. AI is starting to show value not only by helping people work faster but also by helping prevent costly failures.
This changes how healthcare organizations should evaluate AI investments. AI should not be assessed only against software productivity benchmarks. In clinical settings, the calculation may also consider the potential value of preventing harm, reducing liability exposure, strengthening compliance, and making better use of scarce expertise.
Adoption patterns are diverging across markets
Healthcare AI will not scale in the same way everywhere.
Recent guidance from China’s National Health Commission points to a shift from isolated pilots toward more systematic and regulated AI adoption. This signals a broader geopolitical shift: AI in healthcare is increasingly shaped by national priorities, not only by hospital procurement decisions or vendor roadmaps.
The US shows strong clinician demand and high personal tool use, but this can also produce more fragmented adoption. The European markets covered by the report appear more cautious, reflecting stronger governance expectations and institutional controls. This may slow visible adoption in some settings, but it could also create more durable foundations for trust if integration and compliance mature together.
Some Asia-Pacific and Gulf markets may move faster where policy ambition, digital infrastructure, and capacity pressures align. European markets may play a stronger role in defining standards for accountability and patient transparency. The US may continue to generate rapid innovation while facing governance complexity across decentralized systems.
This divergence matters for healthcare organizations, technology providers, and investors. The competitive environment will not be defined only by which companies have the best AI models. It will also be shaped by which organizations can adapt to different regulatory environments, trust expectations, reimbursement structures, and data systems.
Access and equity are becoming strategic priorities
AI is also reframing access to care.
Seventy-five percent of clinicians believe AI can help narrow quality gaps between healthcare settings and improve services in underserved and rural areas. That positions AI as more than an internal efficiency tool. It can become part of the care infrastructure in places where specialist access is limited and workforce shortages are structural.
Remote monitoring, triage support, AI-assisted imaging, clinical documentation, and decision support can extend scarce expertise across wider geographic areas. This does not solve every access problem. Infrastructure, reimbursement, digital literacy, and trust still matter. But AI can help extend access to specialist knowledge.
That creates a different strategic perspective. Rural and underserved care is often discussed as a public health challenge or social obligation. AI may enable more scalable rural-care models by combining broader access, better capacity management, and measurable social impact.
For organizations operating across urban, suburban, and rural networks, the ability to deploy AI as distributed care infrastructure may become a source of advantage.
Trust is now part of the workflow
Patients are becoming more active participants in AI-enabled care. Seventy-four percent of clinicians say patients are arriving with AI-generated health information. Sixty-three percent believe more informed patients will become part of future care teams.
This changes the consultation. Patients may arrive better prepared, with sharper questions and a stronger sense of agency. They may also arrive with misinformation. Sixty-nine percent of clinicians say they have had to correct AI-generated misinformation, potentially placing additional pressure on already limited appointment time.
Transparency is another constraint. Eighty-nine percent of patients say they should be told when AI is used in their care, while 39% of clinicians say they have seen patients lose trust after learning that AI was involved.
Trust can therefore no longer be treated as a communications issue to address after implementation. It has to be designed into the workflow. Patients need to understand where AI is used, what role it plays, and where human judgment remains central. Clinicians need the time and language to explain this clearly.
The hybrid care team is therefore not limited to clinicians and AI. It increasingly includes the AI-informed patient.
The long-term risk is the erosion of clinical capability
The report also points to a slower-moving risk: future clinicians may train in environments where AI is always present.
Many of today’s clinicians developed their professional judgment before AI became part of daily practice. They can compare AI outputs with independently formed clinical reasoning. Future clinicians may not develop the same independent baseline if education, training, and accreditation do not adapt.
Forty-four percent of clinicians already worry about losing clinical skills through overreliance on AI. That concern should not be dismissed as resistance to change. It signals a genuine capability question: How can healthcare preserve clinicians’ ability to audit, challenge, and contextualize AI outputs once AI becomes a routine part of their training?
How healthcare responds could influence clinical quality over the next decade. AI can support better decisions, but only if the workforce retains enough independent expertise to recognize when the system is wrong.
Strategic implications
Healthcare AI is entering its integration phase. Durable advantage will not come from adopting more tools but from building the systems needed to make AI safe, usable, explainable, and embedded in care delivery.
The strongest near-term opportunities lie in workflow efficiency, capacity expansion, error prevention, and access to consolidated patient information. The biggest constraints lie in training, monitoring, interoperability, and trust.
Organizations with connected data, mature governance, and the discipline to protect recovered clinical time will be better positioned than those accumulating disconnected AI applications. Technology partners that reduce fragmentation will matter more than those that simply add isolated features.
The deeper shift is that AI is becoming part of healthcare infrastructure. Not because it replaces clinicians, but because it changes how clinical time, patient information, institutional risk, and access to care are managed.
The next phase will favor health systems that can integrate AI without weakening clinical judgment. That is the real test of scale.
